0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-36N6747
Home | Market Reports | Health| Public Health
Global Foot and Mouth Disease FMD Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2026

Code: QYRE-Auto-36N6747
Report
2026-01-21
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Foot and Mouth Disease (FMD) Vaccines Market Size

The global Foot and Mouth Disease (FMD) Vaccines market was valued at US$ 1152 million in 2025 and is anticipated to reach US$ 2054 million by 2032, at a CAGR of 8.7% from 2026 to 2032.

Foot and Mouth Disease (FMD) Vaccines Market

Foot and Mouth Disease (FMD) Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Foot and Mouth Disease (FMD) Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
Global key players of foot and mouth disease (FMD) vaccines include Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bagó, etc. The top five players hold a share about 59%. China is the largest producer, has a share about 54%, followed by India and Europe, with share 8% and 4%, respectively. The largest market is Asia-Pacific, with a share about 74%, followed by South America and Europe, with share 16% and 4%, separately.
This report delivers a comprehensive overview of the global Foot and Mouth Disease (FMD) Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccines. The Foot and Mouth Disease (FMD) Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Foot and Mouth Disease (FMD) Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Foot and Mouth Disease (FMD) Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Foot and Mouth Disease (FMD) Vaccines Market Report

Report Metric Details
Report Name Foot and Mouth Disease (FMD) Vaccines Market
Accounted market size in 2025 US$ 1152 million
Forecasted market size in 2032 US$ 2054 million
CAGR 8.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Emergency Vaccines
  • Conventional Vaccines
by Application
  • Cattle
  • Pig
  • Sheep & Goat
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bagó, Tecon Group, BIGVET Biotech, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, CEVA, Bayer HealthCare, VECOL, Brilliant Bio Pharma, VETAL, BVI, LIMOR, ME VAC, Agrovet
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Foot and Mouth Disease (FMD) Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Foot and Mouth Disease (FMD) Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Foot and Mouth Disease (FMD) Vaccines Market growing?

Ans: The Foot and Mouth Disease (FMD) Vaccines Market witnessing a CAGR of 8.7% during the forecast period 2026-2032.

What is the Foot and Mouth Disease (FMD) Vaccines Market size in 2032?

Ans: The Foot and Mouth Disease (FMD) Vaccines Market size in 2032 will be US$ 2054 million.

What is the market share of major companies in Foot and Mouth Disease (FMD) Vaccines Market?

Ans: The top five players hold a share about 59%.

What is the Foot and Mouth Disease (FMD) Vaccines Market production share by region?

Ans: China is the largest producer, has a share about 54%, followed by India and Europe, with share 8% and 4%, respectively.

Who are the main players in the Foot and Mouth Disease (FMD) Vaccines Market report?

Ans: The main players in the Foot and Mouth Disease (FMD) Vaccines Market are Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bagó, Tecon Group, BIGVET Biotech, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, CEVA, Bayer HealthCare, VECOL, Brilliant Bio Pharma, VETAL, BVI, LIMOR, ME VAC, Agrovet

What are the Application segmentation covered in the Foot and Mouth Disease (FMD) Vaccines Market report?

Ans: The Applications covered in the Foot and Mouth Disease (FMD) Vaccines Market report are Cattle, Pig, Sheep & Goat, Others

What are the Type segmentation covered in the Foot and Mouth Disease (FMD) Vaccines Market report?

Ans: The Types covered in the Foot and Mouth Disease (FMD) Vaccines Market report are Emergency Vaccines, Conventional Vaccines

1 Foot and Mouth Disease (FMD) Vaccines Market Overview
1.1 Product Definition
1.2 Foot and Mouth Disease (FMD) Vaccines by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Emergency Vaccines
1.2.3 Conventional Vaccines
1.3 Foot and Mouth Disease (FMD) Vaccines by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep & Goat
1.3.5 Others
1.4 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue 2021–2032
1.4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales 2021–2032
1.4.3 Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Foot and Mouth Disease (FMD) Vaccines Market Competition by Manufacturers
2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Foot and Mouth Disease (FMD) Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Date of Entry into the Industry
2.8 Global Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation and Trends
2.8.1 Global Foot and Mouth Disease (FMD) Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue
2.8.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Foot and Mouth Disease (FMD) Vaccines Market Scenario by Region
3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021–2032
3.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021–2026
3.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2027–2032
3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021–2032
3.3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021–2026
3.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2027–2032
3.4 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.4.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021–2032)
3.4.3 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.5.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021–2032)
3.5.3 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021–2032)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021–2026)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027–2032)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021–2032)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021–2026)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027–2032)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021–2032)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021–2026)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027–2032)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021–2032)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021–2026)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027–2032)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jinyu Group
6.1.1 Jinyu Group Company Information
6.1.2 Jinyu Group Description and Business Overview
6.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.1.5 Jinyu Group Recent Developments/Updates
6.2 Cavet Bio
6.2.1 Cavet Bio Company Information
6.2.2 Cavet Bio Description and Business Overview
6.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.2.5 Cavet Bio Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Company Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Shen Lian
6.4.1 Shen Lian Company Information
6.4.2 Shen Lian Description and Business Overview
6.4.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.4.5 Shen Lian Recent Developments/Updates
6.5 Biogenesis Bagó
6.5.1 Biogenesis Bagó Company Information
6.5.2 Biogenesis Bagó Description and Business Overview
6.5.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.5.5 Biogenesis Bagó Recent Developments/Updates
6.6 Tecon Group
6.6.1 Tecon Group Company Information
6.6.2 Tecon Group Description and Business Overview
6.6.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.6.5 Tecon Group Recent Developments/Updates
6.7 BIGVET Biotech
6.7.1 BIGVET Biotech Company Information
6.7.2 BIGVET Biotech Description and Business Overview
6.7.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.7.5 BIGVET Biotech Recent Developments/Updates
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Company Information
6.8.2 Indian Immunologicals Description and Business Overview
6.8.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.8.5 Indian Immunologicals Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Company Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 MSD Animal Health
6.10.1 MSD Animal Health Company Information
6.10.2 MSD Animal Health Description and Business Overview
6.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.10.5 MSD Animal Health Recent Developments/Updates
6.11 CEVA
6.11.1 CEVA Company Information
6.11.2 CEVA Description and Business Overview
6.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.11.5 CEVA Recent Developments/Updates
6.12 Bayer HealthCare
6.12.1 Bayer HealthCare Company Information
6.12.2 Bayer HealthCare Description and Business Overview
6.12.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.12.5 Bayer HealthCare Recent Developments/Updates
6.13 VECOL
6.13.1 VECOL Company Information
6.13.2 VECOL Description and Business Overview
6.13.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.13.5 VECOL Recent Developments/Updates
6.14 Brilliant Bio Pharma
6.14.1 Brilliant Bio Pharma Company Information
6.14.2 Brilliant Bio Pharma Description and Business Overview
6.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.14.5 Brilliant Bio Pharma Recent Developments/Updates
6.15 VETAL
6.15.1 VETAL Company Information
6.15.2 VETAL Description and Business Overview
6.15.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.15.5 VETAL Recent Developments/Updates
6.16 BVI
6.16.1 BVI Company Information
6.16.2 BVI Description and Business Overview
6.16.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.16.5 BVI Recent Developments/Updates
6.17 LIMOR
6.17.1 LIMOR Company Information
6.17.2 LIMOR Description and Business Overview
6.17.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.17.5 LIMOR Recent Developments/Updates
6.18 ME VAC
6.18.1 ME VAC Company Information
6.18.2 ME VAC Description and Business Overview
6.18.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.18.5 ME VAC Recent Developments/Updates
6.19 Agrovet
6.19.1 Agrovet Company Information
6.19.2 Agrovet Description and Business Overview
6.19.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
6.19.5 Agrovet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Foot and Mouth Disease (FMD) Vaccines Industry Chain Analysis
7.2 Foot and Mouth Disease (FMD) Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process Analysis
7.4 Foot and Mouth Disease (FMD) Vaccines Sales and Marketing
7.4.1 Foot and Mouth Disease (FMD) Vaccines Sales Channels
7.4.2 Foot and Mouth Disease (FMD) Vaccines Distributors
7.5 Foot and Mouth Disease (FMD) Vaccines Customer Analysis
8 Foot and Mouth Disease (FMD) Vaccines Market Dynamics
8.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
8.2 Foot and Mouth Disease (FMD) Vaccines Market Drivers
8.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
8.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Foot and Mouth Disease (FMD) Vaccines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Foot and Mouth Disease (FMD) Vaccines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) of Key Manufacturers (2021–2026)
 Table 5. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Foot and Mouth Disease (FMD) Vaccines Average Price (USD/L) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Foot and Mouth Disease (FMD) Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Foot and Mouth Disease (FMD) Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Foot and Mouth Disease (FMD) Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (K L), 2021–2026
 Table 18. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (K L), 2027–2032
 Table 20. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2021–2026
 Table 27. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2027–2032
 Table 28. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2021–2026
 Table 32. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2027–2032
 Table 33. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (K L), 2021–2026
 Table 37. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Region (K L), 2027–2032
 Table 38. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2021–2026
 Table 42. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2027–2032
 Table 43. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2021–2026
 Table 47. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (K L), 2027–2032
 Table 48. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2021–2026)
 Table 51. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Type (2027–2032)
 Table 52. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021–2026)
 Table 53. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2027–2032)
 Table 54. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021–2026)
 Table 57. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2027–2032)
 Table 58. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Type (2021–2026)
 Table 59. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Type (2027–2032)
 Table 60. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2021–2026)
 Table 61. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L) by Application (2027–2032)
 Table 62. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021–2026)
 Table 63. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2027–2032)
 Table 64. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021–2026)
 Table 67. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2027–2032)
 Table 68. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Application (2021–2026)
 Table 69. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Application (2027–2032)
 Table 70. Jinyu Group Company Information
 Table 71. Jinyu Group Description and Business Overview
 Table 72. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 73. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product
 Table 74. Jinyu Group Recent Developments/Updates
 Table 75. Cavet Bio Company Information
 Table 76. Cavet Bio Description and Business Overview
 Table 77. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 78. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product
 Table 79. Cavet Bio Recent Developments/Updates
 Table 80. CAHIC Company Information
 Table 81. CAHIC Description and Business Overview
 Table 82. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 83. CAHIC Foot and Mouth Disease (FMD) Vaccines Product
 Table 84. CAHIC Recent Developments/Updates
 Table 85. Shen Lian Company Information
 Table 86. Shen Lian Description and Business Overview
 Table 87. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 88. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product
 Table 89. Shen Lian Recent Developments/Updates
 Table 90. Biogenesis Bagó Company Information
 Table 91. Biogenesis Bagó Description and Business Overview
 Table 92. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 93. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product
 Table 94. Biogenesis Bagó Recent Developments/Updates
 Table 95. Tecon Group Company Information
 Table 96. Tecon Group Description and Business Overview
 Table 97. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 98. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product
 Table 99. Tecon Group Recent Developments/Updates
 Table 100. BIGVET Biotech Company Information
 Table 101. BIGVET Biotech Description and Business Overview
 Table 102. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 103. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product
 Table 104. BIGVET Biotech Recent Developments/Updates
 Table 105. Indian Immunologicals Company Information
 Table 106. Indian Immunologicals Description and Business Overview
 Table 107. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 108. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product
 Table 109. Indian Immunologicals Recent Developments/Updates
 Table 110. Boehringer Ingelheim Company Information
 Table 111. Boehringer Ingelheim Description and Business Overview
 Table 112. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 113. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product
 Table 114. Boehringer Ingelheim Recent Developments/Updates
 Table 115. MSD Animal Health Company Information
 Table 116. MSD Animal Health Description and Business Overview
 Table 117. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 118. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product
 Table 119. MSD Animal Health Recent Developments/Updates
 Table 120. CEVA Company Information
 Table 121. CEVA Description and Business Overview
 Table 122. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 123. CEVA Foot and Mouth Disease (FMD) Vaccines Product
 Table 124. CEVA Recent Developments/Updates
 Table 125. Bayer HealthCare Company Information
 Table 126. Bayer HealthCare Description and Business Overview
 Table 127. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 128. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product
 Table 129. Bayer HealthCare Recent Developments/Updates
 Table 130. VECOL Company Information
 Table 131. VECOL Description and Business Overview
 Table 132. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 133. VECOL Foot and Mouth Disease (FMD) Vaccines Product
 Table 134. VECOL Recent Developments/Updates
 Table 135. Brilliant Bio Pharma Company Information
 Table 136. Brilliant Bio Pharma Description and Business Overview
 Table 137. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 138. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product
 Table 139. Brilliant Bio Pharma Recent Developments/Updates
 Table 140. VETAL Company Information
 Table 141. VETAL Description and Business Overview
 Table 142. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 143. VETAL Foot and Mouth Disease (FMD) Vaccines Product
 Table 144. VETAL Recent Developments/Updates
 Table 145. BVI Company Information
 Table 146. BVI Description and Business Overview
 Table 147. BVI Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 148. BVI Foot and Mouth Disease (FMD) Vaccines Product
 Table 149. BVI Recent Developments/Updates
 Table 150. LIMOR Company Information
 Table 151. LIMOR Description and Business Overview
 Table 152. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 153. LIMOR Foot and Mouth Disease (FMD) Vaccines Product
 Table 154. LIMOR Recent Developments/Updates
 Table 155. ME VAC Company Information
 Table 156. ME VAC Description and Business Overview
 Table 157. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 158. ME VAC Foot and Mouth Disease (FMD) Vaccines Product
 Table 159. ME VAC Recent Developments/Updates
 Table 160. Agrovet Company Information
 Table 161. Agrovet Description and Business Overview
 Table 162. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 163. Agrovet Foot and Mouth Disease (FMD) Vaccines Product
 Table 164. Agrovet Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Foot and Mouth Disease (FMD) Vaccines Distributors List
 Table 168. Foot and Mouth Disease (FMD) Vaccines Customers List
 Table 169. Foot and Mouth Disease (FMD) Vaccines Market Trends
 Table 170. Foot and Mouth Disease (FMD) Vaccines Market Drivers
 Table 171. Foot and Mouth Disease (FMD) Vaccines Market Challenges
 Table 172. Foot and Mouth Disease (FMD) Vaccines Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Foot and Mouth Disease (FMD) Vaccines
 Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Type: 2025 & 2032
 Figure 4. Emergency Vaccines Product Picture
 Figure 5. Conventional Vaccines Product Picture
 Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Application: 2025 & 2032
 Figure 8. Cattle
 Figure 9. Pig
 Figure 10. Sheep & Goat
 Figure 11. Others
 Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Market Size (US$ Million), 2021–2032
 Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Sales (K L), 2021–2032
 Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Average Price (USD/L), 2021–2032
 Figure 16. Foot and Mouth Disease (FMD) Vaccines Report Years Considered
 Figure 17. Foot and Mouth Disease (FMD) Vaccines Sales Share by Manufacturers in 2025
 Figure 18. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Foot and Mouth Disease (FMD) Vaccines Players: Market Share by Revenue in Foot and Mouth Disease (FMD) Vaccines in 2025
 Figure 20. Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021–2032)
 Figure 23. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021–2032)
 Figure 24. United States Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021–2032)
 Figure 27. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021–2032)
 Figure 35. China Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Foot and Mouth Disease (FMD) Vaccines by Type (2021–2032)
 Figure 56. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Foot and Mouth Disease (FMD) Vaccines by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Foot and Mouth Disease (FMD) Vaccines by Application (2021–2032)
 Figure 59. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/L) by Application (2021–2032)
 Figure 60. Foot and Mouth Disease (FMD) Vaccines Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI